5 Crypto-Centric Stocks to Buy for 2025 as Bitcoin Hits All-Time High
Stocks like NVDA, V, HOOD, SHOP and SQ are poised to benefit from Bitcoin's ongoing rally.
EVgo Stock Plummets as Biggest Investor Sells 23M Shares
EVgo said its largest investor would be selling 23 million shares of Class A common stock, sending them sharply lower Tuesday morning.
Decentralization Is Why We Fight for Crypto
Digital asset laws should enshrine decentralization standards, helping to guard against volatility, scams and casino culture, says a16z’s Miles Jennings.
7 proven strategies to identify potential breakout stocks and boost your investment portfolio
Discovering breakout stocks requires analysis and intuition. Here are seven tips to spot future winners now.
SEC Approves Crypto Wallet Maker Exodus to List on NYSE American After Denying It in May
Exodus will list under its current ticker on NYSE American at the open of trading on Dec. 18
Should You Forget Bitcoin and Buy Ethereum Instead in 2025?
Over the past month and a half, Bitcoin (CRYPTO: BTC) has dominated headlines. In a matter of weeks, the world's largest cryptocurrency surged nearly 50%, ultimately breaking through the $100,000 milestone to set a new all-time high near $107,000. This kind of performance has rightly placed Bitcoin center stage.
Tesla upgraded, MongoDB initiated: Wall Street's top analyst calls
Tesla upgraded, MongoDB initiated: Wall Street's top analyst calls
Pudgy Penguins PENGU Token Debuts at $2.3B Market Cap
$90 million worth of PENGU has traded in its first hour of release.
Trump bump? Fed officials prepare projections into new presidential term
WASHINGTON (Reuters) -Since Donald Trump's election to a second term last month, Federal Reserve policymakers including Chair Jerome Powell have said it is too soon to factor in the U.S. president-elect's yet-to-be-detailed policies into forecasts. But eight years ago Powell as a Fed governor joined the majority of his colleagues in doing just that, meeting records show, bumping up estimates for economic momentum and interest rates to reflect the expected effect of Trump’s tax cuts and other policies. So it may not be all that surprising that a growth upgrade for next year may be back in the cards again this week when Fed policymakers gather to deliver what is expected to be a third interest rate cut and to update their forecasts for growth, unemployment and inflation.
Why Are Teva And Sanofi Stocks Trading Higher On Tuesday?
On Tuesday, Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Sanofi SA’s (NASDAQ:SNY) Phase 2b RELIEVE UCCD study met its primary endpoints in patients with ulcerative colitis (UC) and Crohn’s disease (CD). RELIEVE UCCD investigated duvakitug (TEV’574/SAR447189), a human IgG1-λ2 monoclonal antibody targeting TL1A, for moderate-to-severe inflammatory bowel disease (IBD). In the RELIEVE UCCD study, 36.2% (low-dose) and 47.8% (high-dose) of patients with ulcerative colitis treated with duvakitug